Angiotensin AT1 and AT2 receptors - The battle for health and disease

Nephrology Dialysis Transplantation

Volumn 22, Issue 11, 2007, Pages 3128-3130

  Siragy, Helmy M ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR;

GLOMERULUS; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS SLIT DIAPHRAGM; HUMAN; KIDNEY DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; SHORT SURVEY; SIGNAL TRANSDUCTION;

ANGIOTENSIN II; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; KIDNEY GLOMERULUS; PROTEINURIA; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; REFERENCE VALUES; RENAL CIRCULATION;

EID: 36749100602     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm614     Document Type: Short Survey

References (21)

1. Suzuki K, Han GD, Miyauchi N et al. Angiotensin II type 1 and type 2 receptors play opposite roles in regulating the barrier function of kidney glomerular capillary wall. Am J Pathol 2007; 170: 1841-1853
2. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993; 329: 1456-1462
3. Brenner BM, Cooper ME, de Zeeuw D et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 864-869
4. Lewis EJ, Hunsicker LG, Clarke WR et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345: 851-860
5. Maschio G, Alberti D, Janin G et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med 1996; 334: 939-945
6. Ruggenenti P, Perna A, Gherardi G et al. Renoprotective properties of ACE inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet 1999; 354: 359-364
7. Lafayette RA, Mayer G, Park SK, Meyer TW. Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 1992; 90: 766-771
8. Nakamura T, Obata J, Kimura H et al. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis. Kidney Int 1999; 55: 877-889
9. Benigni A, Tomasoni S, Gagliardini E et al. Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis. J Am Soc Nephrol 2001; 12: 941-948
10. Macconi D, Ghilardi M, Bonassi ME et al. Effect of angiotensin-converting enzyme inhibition on glomerular - basement membrane permeability and distribution of zonula occludens-1 in MWF rats. J Am Soc Nephrol 2000; 11: 477-489
11. Siragy HM. Angiotensin II compartmentalization within the kidney: effects of salt diet and blood pressure alterations. Curr Opin Nephrol Hypertens 2006; 15: 50-53
12. Siragy HM. AT1 and AT2 receptor in the kidney: role in health and disease. Semin Nephrol 2004; 24: 93-100
13. 1 receptor-mediated PGE2 production in conscious rats. J Clin Invest 1996; 97: 1978-1982
14. 2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest 1997; 100: 264-269
15. Siragy HM, Inagami T, Ichiki T, Carey RM. Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc Natl Acad Sci USA 1999; 96: 6506-6510
16. Wolf G, Mueller E, Stahl RAK, Ziyadeh FN. Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells in mediated by endogenous transforming growth factor-β. J Clin Invest 1993; 92: 1366-1372
17. Ferreri NR, Escalante BA, Zhao Y, An S-J, McGiff JC. Angiotensin II induces TNF production by the thick ascending limb: functional implications. Renal Physiology 1998; 274: 148-155
18. 2 receptor in a renal wrap hypertension model. Hypertension 1999; 103: 167-174
19. Siragy HM, Xue C, Abadir P, Carey RM. Angiotensin subtype-2 receptors inhibit renin biosynthesis and angiotensin II formation. Hypertension 2005; 45: 133-137
20. Siragy HM, Inagami T, Carey RM. NO and cGMP mediate angiotensin AT2 receptor-induced renal renin inhibition in young rats. Am J Physiol Regul Integr Comp Physiol 2007. [Epub ahead of print]
21. Oparil S, Yarows SA, Patel S, Fang H, Zhang J, Satlin A. Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial. Lancet 2007; 21: 370: 221-229